Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: A pooled analysis of the NOAH-AFNET 6 and ARTESiA trials — Chuanyi Huang (2024) | RDL Network
Time to benefit and harm of direct oral anticoagulants in device-detected atrial fibrillation: A pooled analysis of the NOAH-AFNET 6 and ARTESiA trials
Professor Gregory Lip, Julius Nikorowitsch, Susanne Sehner, Nina Becher, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Hans‐Christoph Diener, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid N L Hermans, Andrzej Lubiński, Éloi Marijon, Béla Merkely, Lluı́s Mont, Ann‐Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Douglas S. Scherr, Renate B. Schnabel, Ulrich Schotten, Εmmanuel Simantirakis, Tobias Toennis, Panos Vardas, Dan Wichterle, Antonia Zapf, Paulus Kirchhof
Hans‐Christoph Diener, Nina Becher, Susanne Sehner, Tobias Toennis, Emanuele Bertaglia, Carina Blomström‐Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe‐Andrei Dan, Wolfgang Dichtl, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid N L Hermans, Professor Gregory Lip, Andrzej Lubiński, Éloi Marijon, Béla Merkely, ,
Discussion(0)
No comments yet. Be the first to comment.